Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans

Diabetes Technology and Therapeutics

Volumn 11, Issue 9, 2009, Pages 575-580

  Clausen, Trine Schnedler ^a   Kaastrup, Peter ^a   Stallknecht, Bente ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN ASPART; XENON 133;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CATHETER; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; EVALUATION; HUMAN; HUMAN EXPERIMENT; INSULIN PUMP; MALE; MAXIMUM PLASMA CONCENTRATION; MECHANICAL STRESS; NORMAL HUMAN; PRIORITY JOURNAL; TIME TO MAXIMUM PLASMA CONCENTRATION; TISSUE BLOOD FLOW; TREATMENT DURATION;

ABSORPTION; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BLOOD GLUCOSE; BODY MASS INDEX; CATHETERS, INDWELLING; DIET; HUMANS; HYPOGLYCEMIC AGENTS; INFUSION PUMPS, IMPLANTABLE; INSULIN; INSULIN INFUSION SYSTEMS; MALE; REGIONAL BLOOD FLOW; SKINFOLD THICKNESS; SUBCUTANEOUS FAT, ABDOMINAL; TIME FACTORS; XENON RADIOISOTOPES; YOUNG ADULT;

EID: 70349335830     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0058     Document Type: Article

References (34)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853.
3. Haardt MJ, Berne C, Dorange C, Slama G, Selam JL: Efficacy and indications of CSII revisited: the Hotel-Dieu cohort. Diabet Med 1997;14:407-408.
4. Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP: Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes. Diabetes Care 2000;23:1232-1235.
5. Bruttomesso D, Pianta A, Crazzolara D, Scaldaferri E, Lora L, Guarneri G, Mongillo A, Gennaro R, Miola M, Moretti M, Confortin L, Beltramello GP, Pais M, Baritussio A, Casiglia E, Tiengo A: Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. Diabet Med 2002;19:628-634.
6. Wolf FM, Jacober SJ, Wolf LL, Cornell RG, Floyd JC: Quality of life activities associated with adherence to insulin infusion pump therapy in the treatment of insulin dependent diabetes mellitus. J Clin Epidemiol 1989;42:1129-1136.
7. Clausen TS, Kaastrup P, Stallknecht B: Proinflammatory tissue response and recovery of adipokines during 4 days of subcutaneous large-pore microdialysis. J Pharmacol Toxicol Methods 2009 Mar 26 [Epub ahead of print].
8. Murdolo G, Herder C, Wang Z, Rose B, Schmelz M, Jansson PA: In situ profiling of adipokines in subcutaneous micro-dialysates from lean and obese individuals. Am J Physiol Endocrinol Metab 2008;295:E1095-E1105.
9. Pachler C, Ikeoka D, Plank J, Weinhandl H, Suppan M, Mader JK, Bodenlenz M, Regittnig W, Mangge H, Pieber TR, Ellmerer M: Subcutaneous adipose tissue exerts proin-flammatory cytokines after minimal trauma in humans. Am J Physiol Endocrinol Metab 2007;293:E690-E696.
10. Wang X, Lennartz MR, Loegering DJ, Stenken JA: Interleukin-6 collection through long-term implanted micro-dialysis sampling probes in rat subcutaneous space. Anal Chem 2007;79:1816-1824.
11. Wisniewski N, Rajamand N, Adamsson U, Lins PE, Reichert WM, Klitzman B, Ungerstedt U: Analyte flux through chronically implanted subcutaneous polyamide membranes differs in humans and rats. Am J Physiol Endocrinol Metab 2002;282:E1316-E1323.
12. Højbjerre L, Skov-Jensen C, Kaastrup P, Pedersen PE, Stall-knecht B: Effect of steel and Teflon infusion catheters in subcutaneous adipose tissue blood flow and infusion counter pressure in humans. Diabetes Technol Ther 2009;11:301-306.
13. Liu D, Moberg E, Wredling R, Lins PE, Adamson U: Insulin absorption is faster when keeping the infusion site in use for three days during continuous subcutaneous insulin infusion. Diabetes Res Clin Pract 1991;12:19-24.
14. Olsson PO, Arnqvist H, Asplund J: No pharmacokinetic effect of retaining the infusion site up to four days during continuous subcutaneous insulin infusion therapy. Diabet Med 1993;10:477-480.
15. Hanas R, Ludvigsson J: Side effects and indwelling times of subcutaneous catheters for insulin injections: a new device for injecting insulin with a minimum of pain in the treatment of insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1990;10:73-83.
16. Hanas SR, Carlsson S, Frid A, Ludvigsson J: Unchanged insulin absorption after 4 days' use of subcutaneous indwelling catheters for insulin injections. Diabetes Care 1997;20:487-490.
17. Käär ML, Mäenpää J, Knip M: Insulin administration via a subcutaneous catheter. Effects on absorption. Diabetes Care 1993;16:1412-1413.
18. Swan KL, Dziura JD, Steil GM, Voskanyan GR, Sikes KA, Steffen AT, Martin ML, Tamborlane WV, Weinzimer SA: Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care 2009;32:240-244.
19. Larsen OA, Lassen NA, Quaade F: Blood flow through human adipose tissue determined with radioactive xenon. Acta Physiol Scand 1966;66:337-345.
20. Andersen L, Jørgensen PN, Jensen LB, Walsh D: A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequi-valence, and pharmacokinetic studies. Clin Biochem 2000;33:627-633.
21. Hildebrandt P, Sejrsen P, Nielsen SL, Birch K, Sestoft L: Diffusion and polymerization determines the insulin absorption from subcutaneous tissue in diabetic patients. Scand J Clin Lab Invest 1985;45:685-690.
22. Hildebrandt P, Birch K: Basal rate subcutaneous insulin infusion: absorption kinetics and relation to local blood flow. Diabet Med 1988;5:434-440.
23. Kolendorf K, Bojsen J, Nielsen SL: Adipose tissue blood flow and insulin disappearance from subcutaneous tissue. Clin Pharmacol Ther 1979;25:598-604.
24. Wilson GS, Gifford R: Biosensors for real-time in vivo measurements. Biosens Bioelectron 2005;20:2388-2403.
25. Tang L, Eaton JW: Inflammatory responses to biomaterials. Am J Clin Pathol 1995;103:466-471.
26. Wisniewski N, Moussy F, Reichert WM: Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem 2000;366:611-621.
27. Ardilouze JL, Karpe F, Currie JM, Frayn KN, Fielding BA: Subcutaneous adipose tissue blood flow varies between superior and inferior levels of the anterior abdominal wall. Int J Obes Relat Metab Disord 2004;28:228-233.
28. Karpe F, Fielding BA, Ardilouze JL, Ilic V, Macdonald IA, Frayn KN: Effects of insulin on adipose tissue blood flow in man. J Physiol 2002;540:1087-1093.
29. Bü low J, Astrup A, Christensen NJ, Kastrup J: Blood flow in skin, subcutaneous adipose tissue and skeletal muscle in the forearm of normal man during an oral glucose load. Acta Physiol Scand 1987;130:657-661.
30. Kastrup J, Nørgaard T, Parving HH, Henriksen O, Lassen NA: Impaired autoregulation of blood flow in subcutaneous tissue of long-term type 1 (insulin-dependent) diabetic patients with microangiopathy: an index of arteriolar dysfunction. Diabetologia 1985;28:711-717.
31. Kastrup J, Mathiesen ER, Saurbrey N, Nørgaard T, Parving HH, Lassen NA: Effect of strict metabolic control on regulation of subcutaneous blood flow in insulin-dependent diabetic patients. Diabet Med 1987;4:30-36.
32. Hildebrandt P, Mehlsen J, Sestoft L, Nielsen SL: Mild mental stress in diabetes: changes in heart rate and subcutaneous blood-flow. Clin Physiol 1985;5:371-376.
33. Ardilouze JL, Fielding BA, Currie JM, Frayn KN, Karpe F: Nitric oxide and beta-adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans. Circulation 2004;109: 47-52.
34. Patel JN, Eisenhofer G, Coppack SW, Miles JM: Nor-epinephrine spillover in forearm and subcutaneous adipose tissue before and after eating. J Clin Endocrinol Metab 1999;84:2815-2819.